{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-098367","form_type":"8-K","ticker":"ABBV","cik":"0001551152","company_name":"AbbVie Inc.","filed_at":"2026-08-18T20:30:26+00:00","discovered_at":"2026-08-18T20:32:12.595375+00:00","generated_at":"2026-08-18T20:32:25.274546+00:00","sec_items":["8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"AbbVie completes $10B senior notes offering to fund Apogee acquisition","bullets":["Issued $10.0B aggregate principal across 9 tranches: floating rate notes due 2028 and fixed-rate notes from 4.500% due 2028 to 6.100% due 2066.","Net proceeds to fund cash consideration for Apogee Therapeutics acquisition and related fees; remainder for general corporate purposes.","Special mandatory redemption at 101% of principal if Apogee deal terminates before closing (excludes 2056 and 2066 notes).","Notes are unsecured, unsubordinated, rank equally with existing debt; make-whole redemption provisions apply to fixed-rate notes.","Offering completed August 18, 2026; supplemental indenture No. 13 filed with trustee U.S. Bank Trust Company."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-098367","json":"https://secwatch.observer/filing/0001104659-26-098367.json","markdown":"https://secwatch.observer/filing/0001104659-26-098367.md","text":"https://secwatch.observer/filing/0001104659-26-098367.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1551152/000110465926098367/0001104659-26-098367-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1551152/000110465926098367/tm2623337d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-18T20:32:25.274546+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}